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Background. The protein kinase Chk1 is an essential component of the DNA damage checkpoint pathway. Chk1 is
phosphorylated and activated in the fission yeast Schizosaccharomyces pombe when cells are exposed to agents that damage
DNA. Phosphorylation, kinase activation, and nuclear accumulation are events critical to the ability of Chk1 to induce a
transient delay in cell cycle progression. The catalytic domain of Chk1 is well-conserved amongst all species, while there are
only a few regions of homology within the C-terminus. A potential pseudosubstrate domain exists in the C-terminus of S.
pombe Chk1, raising the possibility that the C-terminus acts to inhibit the catalytic domain through interaction of this domain
with the substrate binding site. Methodology/Principal Findings. To evaluate this hypothesis, we characterized mutations in
the pseudosubstrate region. Mutation of a conserved aspartic acid at position 469 to alanine or glycine compromises Chk1
function when the mutants are integrated as single copies, demonstrating that this domain of Chk1 is critical for function. Our
data does not support, however, the hypothesis that the domain acts to inhibit Chk1 function as other mutations in the amino
acids predicted to comprise the pseudosubstrate do not result in constitutive activation of the protein. When expressed in
multi-copy, Chk1D469A remains non-functional. In contrast, multi-copy Chk1D469G confers cell survival and imposes a
checkpoint delay in response to some, though not all forms of DNA damage. Conclusions/Significance. Thus, we conclude
that this C-terminal region of Chk1 is important for checkpoint function and predict that a limiting factor capable of associating
with Chk1D469G, but not Chk1D469A, interacts with Chk1 to elicit checkpoint activation in response to a subset of DNA
lesions.
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INTRODUCTION
The DNA damage checkpoint pathway consists of DNA damage
sensors, signal transducers, and effectors that interface with the cell
cycle machinery to prevent inappropriate transitions when DNA
repair is required. In Schizosaccharomyces pombe the protein kinase
Chk1 is an integral component of the checkpoint pathway,
responsible for transducing a delay signal to the cell cycle
machinery [1,2]. Chk1 is essential for survival in response to
DNA damage, as fission yeast cells lacking the chk1 gene do not
delay cell cycle progression, resulting in hypersensitivity to DNA
damaging agents [1,3]. Likewise, mammalian cells treated with
inhibitors of Chk1 activity are sensitized to killing by DNA
damaging agents [4,5]. Genetic and biochemical dissection of the
checkpoint pathway in S. pombe has uncovered at least eight
additional components that lie at its core (Rad1, Rad3, Rad9,
Rad17, Rad26, Hus1, Cut5, and Crb2), all of which are essential
for Chk1 activation [2,3,6–9] Rad24, a 14-3-3 protein identified as
a checkpoint mutant is also critical for Chk1 function as it binds to
phosphorylated Chk1 and facilitates its nuclear localization
following DNA damage [10,11].
The precise mechanism by which Chk1 is activated in
response to various DNA lesions has yet to be elucidated.
Structurally, Chk1 consists of a highly conserved N-terminal
kinase domain and a C-terminal non-catalytic domain. Evidence
is mounting that critical aspects of Chk1 function are mediated
through the C-terminal domain. We have previously reported
that serine at position 345 in fission yeast Chk1 is phosphory-
lated in vivo and is required to activate Chk1 kinase activity in the
presence of DNA damage [12]. Human Chk1 is also phosphor-
ylated at S345, emphasizing the evolutionary importance of
Chk1 in the checkpoint pathway [13,14]. Phosphorylation at
these SQ sites in mammalian cells and fission yeast is achieved
via ATR and its homolog Rad3, respectively, and is also
dependent on the aforementioned checkpoint proteins [1,2,14–
16]. We and others have demonstrated that phosphorylation of
S345 is critical for an intact checkpoint response, as mutations of
this site that prevent phosphorylation compromise cellular
survival in response to DNA damage [12,16].
Chk1 itself is a serine/threonine kinase that can phosphorylate
the Wee1 tyrosine kinase and the Cdc25 tyrosine phosphatase in
vitro [17,18]. Wee1 and Cdc25 regulate the activity of the cyclin-
dependent kinase Cdc2 that controls entry into mitosis [19].
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Wee1 and Cdc25. We have previously reported that Chk1
possesses a basal level of kinase activity that is elevated at least
two-fold in response to DNA damage [12]. The fact that Chk1
retains a basal level of kinase activity in the absence of
checkpoint induction may explain why overexpression of Chk1
leads to a sustained G2 arrest, which is independent of Chk1
phosphorylation and the checkpoint pathway, and from which
cells cannot recover. While mutating the phosphoacceptor site
(S345A) does not affect Chk1 basal activity, phosphorylation is
critical for Chk1’s increased kinase activity towards substrates in
the presence of damage [12]. Thus, the C-terminus plays a
crucial role in regulating Chk1 catalytic activity in response to
DNA damage.
Studies of Xenopus and mammalian Chk1 support a model
whereby the C-terminus structurally impinges on the N-terminal
domain to suppress Chk1 catalytic activity in the absence of
phosphorylation [20,21]. Specifically, analysis of the Chk1 N-
terminal kinase domain crystal structure reveals that in the
absence of the C-terminal domain, it retains an open
conformation and is 20-fold more catalytically active towards
substrates [21]. Many kinases require phosphorylation within a
region of the catalytic domain, known as the activation loop that
serves as a molecular switch to turn on catalytic activity.
Phosphorylation of a site within this loop secures the conforma-
tion of the activation and catalytic loops by stabilizing a cluster
of positively charged side chains. There is no evidence that Chk1
is phosphorylated within this portion of the catalytic domain
[13]. Indeed, Chk1 appears to have substitutions of specific
residues in the activation loop in lieu of phosphorylation, which
consequently creates a basic environment to stabilize the
activated structure [21].
The observation that Chk1 has enhanced catalytic activity in
the absence of the C-terminal half of the protein strongly suggests
that this region possesses an autoinhibitory domain. An investi-
gation of Xenopus Chk1 demonstrated the presence of a sequence
in the C-terminal domain that could serve to inactivate the protein
in a cell free extract system [22]. A study focusing on a liver-
specific isoform of Chk1 in rat that consists of only the C-terminal
non-catalytic domain demonstrated that this fragment binds to the
kinase domain of the Chk1 protein, consistent with the possibility
that it could act to regulate the protein’s activity [23]. In addition,
a short region of amino acids in the C-terminus of Chk1 resembles
the Chk1 substrate recognition site [24,25]. To test the hypothesis
that this region in the C-terminal domain might act as a
pseudosubstrate to confer autoinhibition, mutations were made
at this site and the phenotypes of cells expressing the mutant
proteins analyzed. The data obtained do not support a role for this
domain as an autoinhibitory site. However, the conserved aspartic
acid residue at position 469 instead emerged as an important site
for Chk1 activity. Specifically, substitution of aspartic acid 469
with glycine confers partial function when expressed in multiple
copies, whereas substitution with alanine exhibits a loss of function
phenotype even in multiple copies. Further investigation of the
D469G mutant revealed that it only functions in multiple copies
when cells are exposed to forms of DNA damage that result in base
modifications or strand breaks. The mutant is non-functional
when cells experience the collapse of replication forks or contain
unligated DNA. This data is consistent with the possibility that
substitution of D469 with glycine allows flexibility in the
conformation of Chk1 that is not permitted when D469 is
substituted with alanine. As a result, the conformational flexibility
conferred by the glycine substitution permits Chk1 to respond to
some, but not all forms of DNA damage.
RESULTS
A putative pseudosubstratedomain in the C-terminus
of Chk1
Using an in vitro kinase assay and variations of a known Chk1
substrate peptide, Hutchins et al. identified a sequence motif for
Chk1 substrate recognition consisting of a hydrophobic residue
(M, I, L, or V) at position –5 and a basic residue (R or K) at
position –3, relative to the phosphoacceptor site [24] (Fig. 1A). A
similar consensus was determined independently by different
investigators [25]. Intriguingly, the sequence context of a region
within the C-terminal domain of Chk1 spanning residues 464-469
matches this Chk1 substrate recognition motif, with a hydrophobic
residue (I464) and a basic residue (R466) at positions –5 and –3
relative to aspartic acid at position 469, occupying the location
that would be substituted with serine in a true substrate. Given the
observation that the isolated kinase domain of Chk1 is more active
than the full-length protein [21], we hypothesized that this region
of Chk1 could act as a pseudosubstrate, permitting the C-terminal
domain to autoinhibit the catalytic domain.
To test this hypothesis, mutations to alanine were made at
positions I464, R466 and D469 as well as the double mutant
I464A,R466A and the triple mutant I464A,R466A,D469A. If
these residues bind the catalytic domain to maintain Chk1 in an
inactive state in the absence of damage, the autoinhibition model
predicts that alanine substitutions at these sites would disrupt such
intra-domain interactions and render Chk1 constitutively active.
Hence, substitutions in the predicted pseudosubstrate domain
should result in an elongated cellular morphology indicative of a
sustained checkpoint delay in the absence of damage. Plasmids
expressing these mutants were introduced into a strain with a
deletion of the chk1 gene and the resulting strains were evaluated
microscopically for an elongated phenotype. Contrary to what
would be expected for constitutively active mutants, the individual
alanine substitutions for I464, R466 and D469 (as well as the
double and triple mutants) did not result in an elongated cellular
phenotype (Fig. 1B). In fact, in the absence of damage, all of the
mutants resemble a control strain transformed with the wild type
plasmid suggesting that mutation of these residues does not affect
cell cycle progression in the absence of damage. The mutants were
also tested for Chk1 checkpoint function as measured by the ability
to survive exposure to DNA damage generated by UV light. As
shown in Fig. 1C, the I464A and R466A mutants, as well as the
double mutant, are as functional as wild type Chk1. Furthermore,
each of these three mutated proteins is phosphorylated in response
to DNA damage generated by the topoisomerase I poison
camptothecin (CPT, Fig. 1D). In contrast, substitution of alanine
for D469 compromises the function of Chk1, rendering cells
sensitive to UV light (Fig. 1E). Thus, while mutating residues
within the hypothetical pseudosubstrate site had no effect on Chk1
activation in the absence of damage, arguing against the
pseudosubstrate hypothesis, mutation of D469 did compromise
function in the presence of DNA damage indicating that the highly
conserved aspartic acid at that position is important for Chk1
function in the DNA damage checkpoint pathway.
Allele specific behavior of mutations at D469
In a previous genetic screen searching for damage-sensitive alleles
of chk1, we identified a mutant with a substitution of glycine for
aspartic acid at position 469 along with substitution of glycine for
aspartic acid at a non-conserved position, 363 [26]. To determine
whether the two mutations contribute independently to Chk1
function, single mutants were constructed to produce Chk1D363G
and Chk1D469G from their own promoters on multi-copy
Damage Specific Chk1 Response
PLoS ONE | www.plosone.org 2 January 2008 | Issue 1 | e1427plasmids. As shown in Fig. 2A, expression of either the
Chk1D363G,D469G or the Chk1D363G protein fails to restore
function to the checkpoint deficient chk1::ura4 strain, suggesting
that D363 is important for function of the fission yeast protein
despite the fact that it is not a well-conserved amino acid [27]. On
the other hand, and to our surprise given the behavior of the
Chk1D469A mutant (Fig. 1E), expression of Chk1D469G fully
restores Chk1 function (Fig. 2A). To determine whether this
response was unique to damage caused by UV light, we exposed
cells to CPT and assayed for a checkpoint response as measured by
a decrease in septation index (SI) in the presence of drug. As
shown in Fig. 2B, chk1::ura4 cells expressing the wild-type protein
(pChk1) exhibit a decrease in SI whereas cells with an empty
vector (pSP1) do not. While cells expressing either pD363G or
pD363G,D469G do not exhibit a drop in SI, indicative of a non-
functional checkpoint, cells expressing the D469G protein are
responsive to CPT (Fig. 2B).
Given the behavior of the Chk1D469G allele expressed on a
multi-copy plasmid, we sought to determine whether the mutant
protein could function when integrated in single copy in the
chromosome. As shown in Fig. 2C, cells with an integrated allele
of chk1D469G behave much like cells with a disrupted copy of chk1
demonstrating that only in multiple copies is the Chk1D469G
protein capable of function. The lack of function when present in
single copy is consistent with the possibility that Chk1D469G
targets, responds to or interacts with a factor that is limiting for the
DNA damage response.
The observation that multiple copies of Chk1D469G confer a
checkpoint response whereas multiple copies of Chk1D469A do
not, led us to consider the basis for this allele specific response and
examine the behavior of the two mutant proteins more closely.
Chk1 is phosphorylated in response to DNA damage and most,
but not all mutations that compromise Chk1 phosphorylation also
compromise checkpoint function [12,26,28]. Phosphorylation can
usually be detected as a mobility shift by SDS-PAGE when epitope
tagged versions of Chk1 are detected with antibody to the tag. As
shown in Fig. 3A, it is possible to detect phosphorylated wild-type
Chk1 when the protein is expressed from the pSP1 plasmid,
though the proportion of shifted Chk1 is less than that observed
when protein produced from integrated alleles of chk1 is examined
Figure 1. Mutation of D469 to alanine in a putative pseudosubstrate domain of Chk1 compromises function. A. Comparison of the region of
fission yeast Chk1 that matches the Chk1 substrate recognition motif [24]. Mutations to alanine were generated at positions 464, 466 and 469 as
indicated. B. The chk1D strains expressing the indicated plasmids, as well as the pSP1 empty vector as a control, were grown to mid-log phase,
ethanol fixed, and DAPI stained for microscopic analysis. Expression of the mutant plasmids does not affect cellular length or morphology as
compared to cells expressing the wt chk1. C. The chk1D strains expressing the indicated plasmids were grown to mid-log phase, spread on PMA
plates in triplicate, exposed to 0, 40, 80, 120, or 160 J/m
2 UV, and incubated for 3 days at 30uC. Mean survival was calculated as the percentage of
colonies appearing on untreated plates. The data shown is from one experiment that is representative of 3 independent experiments. Error bars
represent the standard deviation of the mean. D. Mutations at I464 and R466 do not compromise Chk1 phosphorylation upon exposure to UV light.
Cycling cells were exposed to 40 mM CPT for 2 hours then collected and processed for Western blot analysis with antibody to the HA epitope at the
C-terminus of each of the Chk1 proteins. E. Mutation of D469 to alanine compromises function. Cells were assayed as in B.
doi:10.1371/journal.pone.0001427.g001
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Western blot of a whole cell extract, it was not possible to detect
phosphorylation of Chk1D469G upon exposure to UV light,
despite the robust behavior of the protein in the UV survival assay.
Given the generally strong correlation between phosphorylation
and function, we examined Chk1 phosphorylation more carefully
by immunoprecipitation with the HA antibody followed by
Western blot with an antibody raised against a phosphorylated
serine 345-containing peptide. As shown in Fig. 3B, we were able
to detect a mobility shifted, P-345 reactive form of the
Chk1D469G protein in cells exposed to either UV light (top
panel) or CPT (bottom panel). Consistent with the observation
that Chk1D469A does not function in response to DNA damage,
phosphorylation of this protein was not detected. We conclude
that Chk1D469G is phosphorylated in response to DNA damage,
albeit to a lesser extent than the wild-type protein. Nonetheless,
despite the lower level of phosphorylation relative to the wild-type
protein, Chk1D469G functions well in survival assays.
Phosphorylation of Chk1 normally requires the protein kinase
Rad3 [2,15] as well as several additional components of the
checkpoint pathway that lie upstream of Chk1 and are required
for both Chk1 phosphorylation and initiation of a mitotic delay
[2,6]. To determine if Chk1D469G, with its low level of
phosphorylation, requires Rad3-dependent activation, we trans-
formed the plasmid expressing the mutant protein into a strain
containing a loss of function mutation of rad3 and analyzed the
ability of the strain to survive UV damage. A wild-type strain (972)
with its checkpoint pathway intact is quite resistant to UV damage;
however, loss of Rad3 function severely compromises survival,
even if Chk1 is proficient (Fig. 3C). Similar to a strain expressing
WT Chk1, UV irradiation bears lethal consequences on the
chk1D469G strain when Rad3 function is deficient (Fig. 3C). Thus,
survival of a strain expressing Chk1D469G still requires activation
of the checkpoint pathway by Rad3.
To further characterize the Chk1D469G allele we examined its
catalytic activity using a peptide-based assay. As shown in Fig. 4A,
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Figure 2. When expressed in multiple copies Chk1D469G does not compromise survival in response to UV light or CPT treatment. A. The chk1D
strains transformed with the indicated plasmids were assayed for UV survival as described in Fig. 1B. B. The chk1D strains transformed with the
indicated plasmids were grown to mid-log phase than treated or not with 40 mM CPT for 2 hours. Cells were collected and fixed for staining with
calcofluor to monitor septation index. Graphed data is representative of three independent experiments. A total of 300 cells were counted for each
strain and condition tested. C. A strain with chk1D469G integrated at the genomic chk1 locus does not survive exposure to UV light. The indicated
strains were assayed for UV sensitivity as described in Fig. 1B except that cells were grown and plated on rich media (YEA).
doi:10.1371/journal.pone.0001427.g002
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essentially background levels of kinase activity, approximately
the level of signal observed when the ‘‘kinase dead’’ Chk1D155A
protein is assayed. Yet, activity of Chk1D469G, like that of wild-
type Chk1, is stimulated several fold when the kinase is
immunoprecipitated from cells exposed to UV light. Given the
limited level of catalytic activity exhibited by the Chk1D469G
protein, we wondered whether kinase activity was essential for its
function. Therefore, we created a double mutant of the D469G
allele with the D155A allele, a mutation in a highly conserved
residue present in a multitude of protein kinases that compromises
the catalytic activity of the protein [12]. As shown in Fig. 4B,
mutation of D155A in the context of D469G completely
inactivates the protein with regard to function as measured by
the ability to confer survival upon exposure to UV light. Thus,
while the catalytic activity of the D469G protein is minimal, it is
nonetheless critical for the function of the D469G protein in
conferring survival to a strain that otherwise lacks Chk1 function.
The kinase assay was originally designed to assay Chk1 activity
toward a peptide substrate after a 10-minute incubation time.
However, it is conceivable that the D469G protein may be
activated at a later time period compared to the wild type protein
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Figure 3. Chk1D469G exhibits a low level of phosphorylation in response to UV-irradiation or CPT treatment. A. Chk1D469G fails to display a
mobility shift when whole cell lysates from UV irradiated cells are analyzed by Western blot. The chk1D strains expressing WT Chk1, Chk1D469A,
Chk1D469G, or the empty vector (pSP1) were grown to mid-log phase, irradiated at a dose of 100 J/m
2, and harvested for lysate preparation. Lysates
were separated by SDS-PAGE and examined by Western blot analysis for the HA tag on Chk1. B. The chk1D strains expressing WT Chk1, Chk1D469A,
or ChklD469G were grown to mid-log phase and either treated with 100 J/m
2 UV (upper panels) or 40 mM CPT (lower panels). Lysates were prepared
and subject to immunoprecipitation with the F7 anti-HA antibody. The immunoprecipitates were separated by SDS-PAGE and Western blots were
probed with either the S345-phosphopeptide antibody or the Y11 anti-HA antibody. C. Rad3 activity is required for Chk1D469G survival in response
to UV damage. The WT strain (972) and the chk1D rad3.T80 strains expressing WT Chk1, Chk1D469G, or the empty vector control (pSP1) were grown
to mid-log phase, spread on PMA plates, exposed to 0, 5, 10, 15, or 20 J/m
2 UV, and incubated at 30uC. Survival was determined as described for
Fig. 1B.
doi:10.1371/journal.pone.0001427.g003
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Figure 4. Chk1D469G has catalytic activity that increases in response to DNA damage. A. Chk1D469G has a reduced level of basal activity that
increases in response to UV-irradiation. Chk1, Chk1D469G, and Chk1D155A immunoprecipitates from either untreated or UV-irradiated cells were
assayed for their ability to phosphorylate a peptide substrate. The data shown depicts values for a single experiment with triplicate samples. It is
representative of 3 independent experiments. B. The chk1D strains expressing the indicated plasmids were assayed for sensitivity to UV light as
described in Fig. 1B. C. Chk1 and Chk1D469G immunoprecipitates from either untreated, UV-irradiated, or CPT-treated cells were assayed for their
ability to phosphorylate a peptide substrate over the course of 45 minutes. The reduced level of Chk1D469G catalytic activity is not due to a delay in
the onset of activation. D. Chk1D469A and Chk1D469G immunoprecipitates from either untreated, UV-irradiated, or CPT-treated cells were assayed
for their ability to phosphorylate a peptide substrate over the course of 45 minutes. Chk1D469G displays higher levels of catalytic activity that
increases in response to DNA damage compared to Chk1D469A. The data shown in C and D is representative of 3 independent experiments.
doi:10.1371/journal.pone.0001427.g004
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Therefore, we assayed activation of the mutant protein as
compared to the wild type protein over a 45-minute time course.
As with the single time point assay, WT Chk1 exhibits a basal level
of kinase activity, which is stimulated 3-fold in response to damage
as early as 5 minutes into the assay (Fig. 4C). In contrast,
Chk1D469G exhibited a damage-induced increase in activity that
remained far below the level of basal catalytic activity exhibited by
WT Chk1 even after a 45-minute incubation time (Fig. 4C). As the
low level of activity displayed by Chk1D469G demonstrably
promotes checkpoint activation (Fig. 2A–B), while the
Chk1D469A mutant does not, it was of interest to determine
how the catalytic activity of the checkpoint deficient Chk1D469A
mutant compared to D469G. As shown in Figure 4D,
Chk1D469A possesses a basal level of kinase activity that falls
below the range of basal activity displayed by Chk1D469G.
Interestingly, when UV irradiated, Chk1D469A does undergo an
increase in activity (Fig. 4D). Nevertheless, the level of UV-
induced kinase activation in the Chk1D469A mutant fails to reach
the levels of the damage-induced activation exhibited by the
checkpoint proficient Chk1D469G and is clearly not adequate to
promote checkpoint activation or cellular survival. Thus, it
appears that Chk1D469G unveils threshold levels of phosphory-
lation and catalytic activity that are minimally required to trigger
the DNA damage checkpoint. On the contrary, Chk1D469A with
much lower catalytic activity and devoid of damage-dependent
phosphorylation is incapable of checkpoint activation. These
results suggest that Chk1D469G is partially functional while
D469A represents a loss-of-function allele.
Chk1D469G is checkpoint proficient for UV- or CPT-
induced DNA damage
Cells expressing Chk1D469G display a level of survival to UV-
irradiation that is comparable to that of a strain expressing WT
Chk1, while cells expressing Chk1D469A are much more sensitive.
Todeterminewhetherthedifferenceinsurvivalconferred bythetwo
different alleles is the result of altered abilities to provide checkpoint
function, we tested directly the ability of the mutant proteins to
confer checkpoint function upon exposure to UV light or CPT.
Checkpoint-proficient cells undergo a transient delay in mitotic
entry upon exposure to damage [7]. The damage-dependent
delay, and hence the integrity of the checkpoint, can be examined
in a synchronous population of cells by monitoring the timing of
mitotic entry following transient exposure to UV light or CPT
[11]. As shown in Fig. 5A, this assay confirmed that the checkpoint
is intact in UV-irradiated cells expressing Chk1D469G. While
unirradiated strains begin to enter mitosis approximately 40 min-
utes after the release of the block, UV irradiation causes cells
expressing wild-type Chk1 or Chk1D469G to delay mitotic entry.
In contrast, cells devoid of Chk1 or that express Chk1D469A
begin to enter mitosis at 80 minutes, with 40% of the cell
population binucleate by 100 minutes. A direct comparison of the
survival of cells expressing ChkD469G to cells expressing
Chk1D469A reflects the checkpoint-proficient nature of the
Chk1D469G cells (Fig. 5B). While the Chk1D469A mutant seems
to be as checkpoint-deficient as cells with no Chk1 at all, they
survive better than the chk1 null strain. Reasons for this are unclear
but likely reflect other roles for Chk1 in addition to activation of
the checkpoint that may contribute to cell survival.
Since CPT induces topoisomerase I-mediated DNA strand
breaks primarily during DNA synthesis in S phase [29,30], the
mitotic progression assay was modified in order to monitor the
integrity of the checkpoint after CPT has poisoned topoisomerase
I during S phase. Accordingly, cultures were synchronized in G2
and released for approximately 30 minutes to proceed through the
first synchronous mitosis before treating with CPT in the
subsequent S phase. The cells were subjected to 1 hour of CPT
treatment, after which the drug was washed out to allow cells to
recover and proceed to the second mitosis. Consequently, timing
of mitotic entry was monitored over two periods of cell division. As
shown in Fig. 6A, all strains proceed synchronously through the
first mitosis. Entry into the next mitotic phase is delayed for
approximately 60 minutes for cells expressing either wild-type
Chk1 or Chk1D469G as a result of being challenged with CPT
(Fig. 6A, compare closed to open symbols). When plotted, this
mitotic delay manifests itself as a shift in the peak of percent
binucleate cells from 240 minutes to 300 minutes.
In contrast, cells expressing Chk1D469A fail to delay mitotic
entry in response to damage, as Chk1D469A cells exposed to CPT
(Fig. 6B, closed triangles) proceed through mitosis with the same
kinetics as the untreated strains (Fig. 6B, open symbols). Thus, the
mutation of aspartic acid 469 to a glycine residue allows Chk1 to
respond to UV irradiation and CPT treatment to maintain
checkpoint function. On the contrary, an alanine substitution at
this residue renders Chk1 defective and unable to execute a
checkpoint-dependent delay when faced with UV or CPT-
mediated DNA damage. As is the case for UV-induced damage,
the checkpoint proficiency exhibited by the Chk1D469G allele
translates into better survival for the strain in response to CPT
treatment (Fig. 6C). On the other hand, and as was the case for
UV damage, while the checkpoint deficiency exhibited by
Chk1D469A correlates with poor survival, it does not render cells
as sensitive to CPT as a chk1 null strain (Fig. 6C).
Chk1D469G is checkpoint deficient for some types
of DNA damage
It has been reported that the C-terminal region of Chk1 may
activate the checkpoint in response to distinct DNA damage
lesions [28,31]. Therefore, to assess checkpoint functions of
Chk1D469A and Chk1D469G we evaluated the ability of the
mutant alleles to support survival upon generation of a variety of
other types of DNA damage. As shown in Fig. 7A, cells expressing
Chk1D469G survive exposure to an alkylating agent, MMS, or the
UV-mimetic, 4-NQ. In contrast, cells expressing Chk1D469A
exhibit sensitivity to these agents. We also examined sensitivity of
these strains to double strand breaks generated by exposure of cells
to gamma radiation. As shown in Fig. 7B, while cells expressing
Chk1D469G are not as resistant as cells expressing wild-type
Chk1, they are more resistant than cells expressing Chk1D469A or
those that lack Chk1 altogether.
We also introduced these mutant alleles into strain backgrounds
that would allow the generation of other DNA damage structures,
specifically collapsed replication forks or unligated DNA. The cds1
gene encodes a protein kinase with a primary role in S-phase [32].
Cds1 is essential for survival when DNA replication is inhibited by
treatment with the inhibitor of ribonucleotide reductase, hydroxyurea
(HU), presumably due to a role in stabilizing replication forks that
have stalled as a result of depleted pools of ribonucleotide [32–34].
Cells lacking Cds1 (cds1D) that have been exposed to HU
exhibit activation of the DNA damage checkpoint as manifested
by phosphorylation of Chk1 [34]. In the absence of Chk1, if cds1D
cells are exposed to HU they undergo aberrant mitosis and display
a ‘‘cut’’ phenotype, which is characterized by inappropriate
nuclear division by the septa or uneven nuclear division leading to
anucleate or aneuploid cells [32]. Strains expressing Chk1D469G
or Chk1D469A display a high percentage of cells with the cut
Damage Specific Chk1 Response
PLoS ONE | www.plosone.org 7 January 2008 | Issue 1 | e1427phenotype in the presence of 12 mM HU (Fig. 8A), while a cds1D
chk1D strain expressing the wild-type chk1 plasmid displays only
4.6% cut cells after 4 hours of HU treatment (Fig. 8A).
Limiting the activity of DNA ligase demands checkpoint
activation for cell survival [7,35]. The mutant form of DNA
ligase encoded by cdc17-K42 is functional at 25uC and completely
non-functional at 36.5uC resulting in a block to cell cycle
progression [36]. At an intermediate temperature of 32uC the
Cdc17-K42 protein is partially functional prompting unligated
Okazaki fragments to activate the checkpoint to induce a Chk1-
dependent cell cycle delay [7,35]. Consequently, a chk1 deletion
strain renders the cdc17-K42 strain inviable at 32uC and can be
exploited to test the checkpoint function of chk1 alleles [26].
Expressing WT Chk1 allows colony formation at 32uC; however,
like the empty vector control, expression of Chk1D469A mutant
fails to allow colony formation and expression of Chk1D469G
allows only minimal colony formation (Fig. 8B).
DISCUSSION
We have identified a Chk1 variant harboring a mutation in a
highly conserved region of its C-terminus (Chk1D469G) that
renders cells competent to withstand UV and CPT-induced DNA
lesions, while an alanine substitution of the D469 residue
(Chk1D469A) renders cells checkpoint deficient. The allele
specificity of the UV/CPT resistance phenotype observed for
Chk1D469G, coupled with the fact that the mutation lies within a
region ofthe kinasethat is highlyconservedinevolutionarilydistinct
organisms, indicates that this C-terminal segment of Chk1 may be
critical for detecting or responding to DNA damage signals.
We have previously shown that a prerequisite for a DNA
damage-induced mitotic delay is phosphorylation of Chk1 on a
critical C-terminal serine residue (S345) in a manner that requires
the ATM/ATR-like kinase Rad3 [2]. The DNA damage-
dependent phosphorylation of Chk1 has proven to be an adequate
indication of checkpoint activation and is well-recognized in
numerous model systems [37,38]. Not only does Chk1 phosphor-
ylation reflect checkpoint activation, but it also correlates well with
robust survival following UV or CPT exposure [12,26]. While
Chk1D469G confers levels of survival that parallel the WT strain
in response to either CPT or UV treatment, the level of
phosphorylation of the mutant protein is much reduced as
compared to wild type. Nonetheless, Chk1D469G is competent
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PLoS ONE | www.plosone.org 8 January 2008 | Issue 1 | e1427to induce a checkpoint dependent cell cycle delay. The ability of
Chk1 mutants to function proficiently with minimal levels of
phosphorylation is not unprecedented. Two independent groups
observed that other C-terminal fission yeast mutants in the vicinity
of D469G (E472D and I484T) exhibit significantly reduced
phosphorylation levels and yet are checkpoint proficient [28,31].
Interestingly, in an effort to elucidate the minimal structural
requirements for checkpoint activation, Xenopus egg extracts were
utilized to demonstrate that the length of single stranded DNA
between the free ends of primed DNA, influenced the degree of
Chk1 phosphorylation [39]. Perhaps the Chk1D469G protein
interacts less efficiently with the damage signaling complex,
thereby reducing the level of signaling to Chk1.
We have previously shown that Chk1 catalytic activity is crucial
to elicit the DNA damage checkpoint response [12]. Evidence
from mammalian cells, Xenopus, and fission yeast have established
that Chk1 kinase activity is elevated in response to DNA damage
signals, however, the precise mechanism of Chk1 activation has
yet to be elucidated [12–14,31,40]. It has been hypothesized that
the C-terminus of Chk1 acts to regulate its kinase activity by
suppressing Chk1 catalytic activity until it is phosphorylated, at
which point a conformational change leads to derepression of the
catalytic domain. This conjecture is supported by both the crystal
structure of the Chk1 catalytic domain and mutational studies that
reveal C-terminal disruptions of Chk1 exhibit increased intrinsic
kinase activity even in the absence of damage [21].
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terminal domain of Chk1 may have a negative impact on its
catalytic activity, we might have expected that the checkpoint
proficient Chk1D469G mutant would display an elevated level of
kinase activity both in the absence and presence of damage.
However, we observed that Chk1D469G had significantly reduced
basal activity that was stimulated greater than two-fold in response
to damage and was apparently sufficient to enforce a mitotic delay.
This implies that there is a threshold level of activity that is
adequate to activate the checkpoint, and that WT Chk1 is
normally activated in excess of the level that is minimally required
to enforce a delay. Alternatively, it is possible that the absolute
level of activity is not the critical factor for Chk1 function, but
rather a change in magnitude of Chk1 activity may very well be
the important parameter. It is noteworthy that a role for Chk1 in the
spindle checkpoint has begun to emerge, requiring only the basal
catalytic activity of Chk1 for function [41]. Phosphorylation of Chk1
in Xenopus in response to spindle perturbations does not affect the
sites conventionally targeted by the ATM/ATR kinases. This
suggests that either ATM/ATR have the potential to mediate
phosphorylation of Chk1at non-canonical sites, oralternatively, that
phosphorylation is mediated by another caffeine-sensitive kinase.
Based on the substrate specificity determinants for Chk1 [24],
we hypothesized that the region containing D469 might serve as a
pseudosubstrate recognition site that mediates an autoinhibitory
interaction with the catalytic domain. While it is quite possible that
Chk1 is regulated by autoinhibition, we have shown here that
mutationsoftheC-terminal residuesI464 and R466 to alanine donot
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PLoS ONE | www.plosone.org 10 January 2008 | Issue 1 | e1427render Chk1 in a constitutively activated state. The I464A and
R466A mutants retain function, though mutation of D469 to alanine
inactivates the protein, both in terms of checkpoint function and
catalytic activity. Intriguingly, mutation to glycine allows some
function when Chk1D469G is expressed at greater than one copyper
c e l l ,t h o u g ho n l yw h e nc e l l sa r ec h a l l e n g e dw i t hs o m et y p e so fD N A
damage. Glycine residues have a well-characterized architectural role
in proteins as they often enable helical turns and bends (see for
example [42]). In fact it has been suggested that glycine residues may
be essential for switching proteins between distinct functional states
because of the conformational freedom they provide to the protein
backbone. We speculate that the glycine substitution creates a flexible
h i n g et h a tp e rm i t sC h k 1t oe xi s ti na no p e nc o n f o r ma t i o n .A sar e s u lt ,
Chk1D469G is maintained in a functional state poised for mediating
interactions with components of the checkpoint pathway albeit with
reduced levels of phosphorylation and catalytic activity.
Alternatively, it is also possible that the Chk1D469G mutant is
simply a partial, rather than complete, loss-of-function mutant.
The ability of the D469G mutant to partially restore DNA
damage-induced checkpoint function only when present in
multiple copies supports this possibility, though it does not explain
why Chk1D469G supports survival in response to some, but not
all forms of DNA damage. To account for this observation, one
might imagine that different types of DNA damage may demand
different levels of Chk1 activity to promote survival. The reduced
activity of Chk1D469G may be sufficient for lesions arising from
base modifications or strand breaks, but not for conditions that
generate collapsed forks or unligated DNA.
This is not the first report of lesion specific activation of fission
yeast Chk1. Indeed, it has been reported that a particular set of
chk1 mutants can distinguish between lesions induced in G2 phase
and structures generated by collapsed replication forks, and that
these signal distinct checkpoint responses [28]. The mechanisms
used by checkpoints to recognize different classes of DNA lesions
are not clear. Some reports suggest that the ATM and ATR
kinases target specific checkpoint components depending on the
genomic lesion identified, while others suggest that it is not in fact
lesion recognition, but the processing of diverse lesions by distinct
DNA repair factors which ultimately recruits and activates
particular checkpoint components [43,44]. While the precise
checkpoint activating structure remains elusive, studies in Xenopus
suggest that ongoing replication may in fact alter the minimal
requirements for checkpoint activation [39]. Thus, checkpoint
activation during S phase likely differs from activation when
replication has been completed.
Chk1 interacting proteins that promote damage specific
responses have been identified. The BRCT motif-containing
adaptor protein Crb2, which is required for Chk1 activation is
0
10
20
30
40
50
60
70
012345
Time (hours)
P
e
r
c
e
n
t
 
A
b
e
r
r
a
n
t
 
M
i
t
o
s
i
s
p
p+ H U
p
p + H U
p
p + H U
pSP1
pSP1+HU
25°C 32°C
p
p
p
p
pSP1
Figure 8. Chk1D469G cannot confer checkpoint function when replication forks stall or when DNA ligase activity is limited. A. A cds1D chk1D
strain was transformed with the plasmids indicated in the legend. Mid-log phase cells were treated with 12 mM HU for the indicated period of time
and monitored for the percentage of cells displaying aberrant mitosis. The key depicts cellular morphologies scored as aberrant mitosis. B. A chk1D
strain transformed with WT Chk1 (cdc17
+/pChk1) and chk1D cdc17-K42 strains transformed with the indicated plasmids were grown to mid-log phase,
resuspended to 1610
7 cells/ml and 10-fold serial dilutions were spotted on PMA plates. The plates were incubated at 25u and 32uC for 3 days.
doi:10.1371/journal.pone.0001427.g008
Damage Specific Chk1 Response
PLoS ONE | www.plosone.org 11 January 2008 | Issue 1 | e1427required for checkpoint signaling induced by UV, methyl-methane
sulfonate (MMS) and ionizing radiation, but is dispensable when
cells are exposed to HU [6,45]. However, we observe that
supplying Crb2 in excess cannot rescue the survival of the single-
copy checkpoint-deficient Chk1D469G mutant (unpublished
data). In a Xenopus system, depletion of Claspin, a mediator
protein for Chk1 activation, eliminates Chk1 phosphorylation in
response to stalled replication forks, but depletion of both Claspin
and BRCA1 is necessary to eliminate Chk1 phosphorylation when
the damage signal arises from a double strand break [46]. By
analogy, it is possible that Chk1D469G responds to some, but not
all mediators of the DNA damage signal in S. pombe. We
anticipate that an unbiased genetic screen to identify such factors
that can support survival when Chk1D469G is present in single
copy may reveal additional mediators that contribute to damage
specific checkpoint responses.
A thorough understanding of the mechanism of Chk1-dependent
checkpoint activation is critical for the development of anti-cancer
strategies, as it is apparent that inactivating Chk1 can sensitize cells
to genotoxic therapies [4,5]. While loss-of-function alleles of Chk1
havebeen keyto definingtherole ofChk1 inthe cellularresponseto
DNA damage, it is clear that our understanding of the checkpoint
response is far from complete. Mutant alleles of Chk1 provide
valuable tools for genetically dissecting the checkpoint pathway and
ultimately may contribute to the determinationof how best to target
Chk1 for therapeutic efficacy.
MATERIALS AND METHODS
Plasmids, yeast strains, media, and growth conditions
Strains used in these studies are listed in Table 1. Mutations of chk1
were constructed using as a PCR template the S. pombe chk1 gene,
containing 3 copies of the HA-epitope, cloned into the pSP1
multicopy plasmid [47]. Site-directed mutagenesis was performed
using the Quick Change Site-Directed Mutagenesis Kit (Strata-
gene) to create the chk1D363G, chk1D469G, chk1D469A,
chk1I464A,and chk1R466A point mutations. Mutations of the
cDNA for chk1 were also generated via site-directed mutagenesis,
using as a template the HA-tagged chk1 cDNA cloned into the
pRep1 vector [48]. To confirm that only the desired base changes
were established, the entire coding region of each chk1 allele was
sequenced. Subsequently, the plasmids were transformed using the
LiAc transformation method as described into an S. pombe strain in
which the endogenous copy of the chk1 gene was disrupted with
the ura4 auxotrophic marker (chk1::ura4 strain) [2]. HindIII or
EcoRV fragments of genomic chk1 alleles generated in pSP1 or
pSP1-chk1epDHA, respectively, were integrated into the S. pombe
genome by gene replacement of the chk1::ura4 allele as described
previously for integration of the chk1:ep allele [2]. Southern blot
analysis was performed to confirm integration of the mutant chk1
alleles at the correct locus. Strains harboring plasmids were grown
in Pombe Minimal (PM) medium made from Edinburgh Minimal
Medium (Bio-101), prepared according to the manufacturers
instructions and supplemented with adenine at 75 mg/ml (PMA).
For the checkpoint assay, stains harboring the plasmid were grown
in Synthetic Complete (SC) dropout medium supplemented with
the appropriate amino acids at 75 mg/ml. Strains containing the
alleles of chk1 integrated into the genome were grown in rich yeast
extract supplemented with adenine at 75 mg/ml (YEA) [49]. All
strains were grown at 30uC, except in experiments utilizing
temperature sensitive mutants. In experiments utilizing strains
containing plasmids under the control of the nmt1 thiamine
repressible promoters, 20 mM thiamine was added to the medium
to repress protein expression.
Genotoxic treatments
Camptothecin lactone (CPT) was obtained from the Drug Synthesis
and Chemistry Branch, Developmental Therapeutics Program,
Division of Cancer Treatment, National Cancer Institute. To
analyze for Chk1 phosphorylation, exponentially growing cells were
treated with 40 mM CPT for 2.5 hours as described [37]. To
determine CPT sensitivity, strains were grown in liquid culture to
mid-log phase, serially diluted ten-fold, and 5 ml aliquots were
spotted on PMA plates containing 0, 15, and 20 mMC P T .T o
determine sensitivity to ionizing radiation, cells from log phase
cultures were plated onto PMA plates at the appropriate
concentration. The plates were exposed to ionizing radiation using
a Cobalt
60source(Gammacell-220 Irradiator) for timescalculated to
deliver the indicated doses. Plates were incubated for 3–5 days at
30uCand colonieswerecounted.UVsurvivalassayswereperformed
as described [1]. To treat liquid cultures with UV, cells were
collected on Durapore Membrane Filters (Millipore) via aspiration.
The filters were UV irradiated and subsequently dropped into fresh
media to release the irradiated cells from the filters. For treatment
with hydroxyurea (HU), cells were incubated in the presence of
12 mM HU for up to 5 hours. Aliquots were taken at hourly
intervals and fixed with 70% ethanol. To measure aberrant mitosis,
the fixed cells were stained with Calcofluor to detect septa and 4,6-
diamidino-2-phenylindole (DAPI) to visualize nuclei.
Checkpoint Assays
Synchronous cultures were tested for the ability to arrest cell cycle
progression in response to UV treatment as described [11] except
that cells were propagated in SC-Leu drop out media to maintain
the plasmids, and cells were fixed in ethanol for DAPI staining.
For UV treatment, G2 arrested cells were collected on Durapore
Millipore filters by aspiration, irradiated with 100 J/m
2 UV,
immediately washed off the filters into fresh SC-Leu media, and
incubated at permissive temperature for 4 hours. To CPT treat
synchronized cells, G2 arrested cells were released to permissive
temperature for 30-minutes at which time they were treated with
20 mM CPT. Following 1 hour of treatment, the CPT was washed
out, cultures were resuspended in fresh SC-Leu media, and
maintained at permissive temperature for an additional 6 hours.
Aliquots were collected every 309, starting from the initial release
to permissive temperature, and ethanol fixed for DAPI staining.
Lysatepreparation,immunoprecipitation,andimmuno-
blotting
Cell lysates were extracted with IP buffer (10 mM NaPO4 pH 7,
0.15 M NaCl, 1% NP40, 10 mM EDTA, 50 mM NaF, 2 mM
DTT, 50 mM PMSF, 50 mM Na-O-Va, and Complete Protease
Inhibitors (Roche Diagnostics)). Cells were lysed using glass beads
in a Fast Prep vortexing machine (Bio 101). The lysate was
collected by centrifugation at 1000 RPM for 1 minute and spun
for an additional 5 minutes at 5000 RPM to rid of cellular debris.
SDS-PAGE and immunoblotting was performed as described [2].
For Chk1 immunoprecipitation, cells were lysed in IP buffer
and 10 mg of the protein extracts was added to 100 mL of F7 anti-
HA antibody (Santa Cruz). Each IP was brought up to a 500 ml
volume and incubated at 4uC on a rotator for 1 hour, followed
bythe incubation with 50 ml of protein A sepharose beads for
1 hour at 4uC. Subsequently, the IP’s were washed three times in
IP buffer and 120 mlo f2 6Laemmli sample buffer was added to
the dry beads. After a 5-minute boil, the IP’s were split into 55 ml
aliquots, run on 8% SDS-PAGE gels, and transferred to nitrocel-
lulose for immunodetection with the Y11 anti-HA antibody at a
1:1000 dilution (Santa Cruz). To detect phosphorylated Chk1, the
Damage Specific Chk1 Response
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Chk1 phosphorylated on S345, at a dilution of 1:1000 [12].
Kinase Assay
Chk1 catalytic activity was assessed via in vitro kinase assays using
1–2 mg of protein per reaction as described [12]. For these kinase
assays, Chk1 was immunoprecipitated with 40 mL F7 anti-HA
antibody and 20 mL protein A sepharose beads.
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Table 1. Strains Used.
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Strain Genotype
972 h
2 (wild-type)
NW158 h
+ chk1::ura4 ura4-D18 leu1-32 ade6-216
NW223 h
+ chk1:HA3 leu1-32 ade6-216
NW554 h
+ chk1::ura4 ura4-D18 leu1-32 ade6-216/pREP1chk1:HA3
NW569 h
+ chk1::ura4 ura4-D18 leu1-32 ade6-216/pREP1
NW740 h
+ chk1::ura4 ura4-D18 leu1-32 ade6-216/pSP1chk1S345A:HA3
NW1503 h
+ chk1::ura4 ura4-D18 leu1-32 ade6-216/pSP1chk1D469G:HA3
NW1504 h
+ chk1::ura4 ura4-D18 leu1-32 ade6-216/pSP1:chk1D363G,D469G:HA3
NW1505 h
+ chk1::ura4 ura4-D18 leu1-32 ade6-216/pSP1
NW1506 h
+ chk1::ura4 ura4-D18 leu1-32 ade6-216/pSP1chk1:HA3
NW1507 h
+ chk1::ura4 ura4-D18 leu1-32 ade6-216/pREP1chk1D469G:HA3
NW1508 h
+ chk1::ura4 ura4-D18 leu1-32 ade6-216/pSP1chk1S345A,D469G:HA3
NW1509 h
+ chk1D469G:HA3 leu1-32 ade6-216
NW1510 h
+ rad3.T80 chk1::ura4 ura4-D18 leu1-32 ade6-216/pSP1chk1:HA3
NW1511 h
+ rad3.T80 chk1::ura4 ura4-D18 leu1-32 ade6-216/pSP1chk1D469G:HA3
NW1512 h
+ rad3.T80 chk1::ura4 ura4-D18 leu1-32 ade6-216/pSP1
NW1513 h
+ chk1::ura4 ura4-D18 leu1-32 ade6-216/pSP1chk1D155A,D469G:HA3
NW1514 h
+ chk1::ura4 ura4-D18 leu1-32 ade6-216/pSP1chk1D155A:HA3
NW1515 h
+ chk1::ura4 ura4-D18 leu1-32 ade6-216/pSP1chk1D469A:HA3
NW1516 cdc2-3w cdc25:ura4 chk1::ura4 ura4-D18 leu1-32 ade6-216/pSP1chk1:HA3
NW1517 cdc2-3w cdc25:ura4 chk1::ura4 ura4-D18 leu1-32 ade6-216/pSP1chk1D469G:HA3
NW1518 cdc2-3w cdc25:ura4 chk1::ura4 ura4-D18 leu1-32 ade6-216/pSP1
NW1519 h
+ cdc17-K42 chk1::ura4 ura4-D18 leu1-32 ade6-216/pSP1chk1:HA3
NW1520 h
+ cdc17-K42 chk1::ura4 ura4-D18 leu1-32 ade6-216/pSP1chk1D469G:HA3
NW1521 h
+ cdc17-K42 chk1::ura4 ura4-D18 leu1-32 ade6-216/pSP1
NW1522 cds1::ura4 chk1::ura4 ura4-D18 leu1-32 ade6-216/pSP1chk1:HA3
NW1523 cds1::ura4 chk1::ura4 ura4-D18 leu1-32 ade6-216/pSP1chk1D469G:HA3
NW1524 cds1::ura4 chk1::ura4 ura4-D18 leu1-32 ade6-216/pSP1
NW1858 h
+ chk1::ura4 ura4-D18 leu1-32 ade6-216/pSP1chk1I464A:HA3
NW1859 h
+ chk1::ura4 ura4-D18 leu1-32 ade6-216/pSP1chk1R466A:HA3
NW1860 h
+ chk1::ura4 ura4-D18 leu1-32 ade6-216/pSP1chk1I464A,R466A:HA3
NW1861 h
+ chk1::ura4 ura4-D18 leu1-32 ade6-216/pSP1chk1I464A,R466A,D469A:HA3
doi:10.1371/journal.pone.0001427.t001
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